Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study

Por van Halm, Vokko P, Nurmohamed, Michael T, Twisk, Jos WR, Dijkmans, Ben AC, Voskuyl, Alexandre E
Publicado em 2006